Our previous studies have demonstrated that retrovirus-mediated gene transduction of either the human erythropoietin receptor (EpoR) or H-ras cDNA into single purified hematopoietic progenitor (HPC), CD34 
regulatory elements. The hematopoietic system, one of the stem cell systems, is a useful experimental model for analyzing this coordination because more than eight distinct blood cell lineages arise from single multipotential hematopoietic stem cells within a relatively short period. 1 Erythropoiesis is one major pathway by which a pluripotent hematopoietic stem cell gives rise to mature end stage cells. The biology of this pathway has been intensively studied because of its clinical importance and its utility as a model system for the study of cell differentiation. During erythropoiesis, the stem cell changes into a highly specialized cell, making large quantities of hemoglobin within a cell membrane modified to allow survival for long periods of time in the circulation. These processes are ultimately caused by changes in the activities of various genes and their products, such as cytokines, that confer the erythroid phenotype to the hematopoietic stem cell. 2 Erythropoietin (Epo) is a lineage-specific hematopoietin required for survival, proliferation and differentiation of committed erythroid progenitor cells. 3 Its major effects are to promote erythroid differentiation and to initiate hemoglobin synthesis. Therefore, Epo has been identified as the major hormone required for erythropoiesis. Epo exerts its function through the Epo receptor (R), a member of the class I cytokine receptor family. Both Epo and EpoR are essential for the production of red blood cells, and knock out of either Epo or EpoR genes results in embryonic lethality due to the lack of definitive erythropoiesis. 3 In contrast, recent evidence demonstrated that even in the absence of Epo or EpoR, almost normal numbers of erythroid progenitors are generated, indicating that Epo and EpoR are not required for the commitment of hematopoietic stem cells to the erythroid lineage but are required for the terminal differentiation of those committed progenitors. 4, 5 The Ras family comprises H-Ras, K-Ras 4A, K-Ras 4B, N-Ras, and other homologous proteins. Ras protein function is controlled by a guanosine triphosphate-guanosine diphosphate (GTP-GDP) cycle. 6, 7 Ras proteins are proto-oncogene products that are critical components of signaling pathways leading from cell surface receptors to the control of cellular proliferation, differentiation or cell death. Ligand-stimulated activation of the cell surface receptor, receptor-associated tyrosine kinases, or agonists mediated through G protein-coupled receptors results in the activation of Ras proteins. 7, 8 Signaling pathways transmitted through Ras further activate Ras effector molecules, the best characterized of which is the serine/threonine kinase Raf. Through interaction with Raf, Ras activates the MEK 1 and 2 kinases and, in turn, activates the ERK 1 and 2 kinases. 9 Considerable progress has been made in our understanding of the developmental relationships within the ras gene family. The various Ras proteins also present some differences in their post-translational processing. Recent evidence indicates that Ras genes are involved in cell differentiation as well as proliferation. H-Ras is one member of this family, and it has been activated most frequently in tumors of epidermal origin. 10, 11 The activated H-Ras oncogene induces AP1-site DNA-binding activity via induction of c-jun transcription in F9, a murine embryonic carcinoma cell line. Activation of H-ras and c-jun both induce the differentiation of F9 cells to endoderm-like cells. 12 Our previous studies demonstrated that retrovirusmediated gene transduction of human (h) EpoR cDNA into single highly purified hematopoietic stem/progenitor cells or their single daughter progenitor cells from human umbilical cord blood (CB) resulted in increased numbers of detectable Epo-responsive erythroid progenitors. 13, 14 This increase was further enhanced by co-transduction of both EpoR and the interleukin (IL)-9 receptor cDNAs. 15 We have also reported that transduction of H-Ras cDNA into the human erythroleukemic TF1 cell line and human CD34
+ CB cells resulted in increased numbers of red cellcontaining colonies and increased expression of erythroidspecific gene expression associated with an induced premRNA of the hEpoR gene. 16 In order to better understand the interacting effect between hEpoR and H-ras genes on the proliferation and differentiation of primary hematopoietic cells, we constructed retroviral vectors containing Hras or hEpoR cDNA and evaluated their biological effects by simultaneous co-transduction of both EpoR and H-ras genes into single CD34 3+ CB cells.
Materials and methods

Cells
Cells were obtained from normal human umbilical CB scheduled for discard after delivering of the infant and after prior need for samples for clinic study had been satisfied. CD34 + cells (90% to 95% pure) were isolated with MACS bead (Miltenyi Birtee Auburn, CA, USA) based on the manufacturer's instruction. CD34 3+ cells were obtained after sorting MACS separated CD34 + cells on a flow cytometer (Facstar plus , Becton Dickinson, San Jose, CA, USA) with FITC-conjugated anti-human CD34 antibody (anti-HPCA-2) or FITC-conjugated mouse IgG 1 antibody, as a control, purchased from Becton Dickinson Immunocytometry System (San Jose, CA, USA) as previously described. [13] [14] [15] [16] [17] The CD34
3+ cells constitute 20-30% of total CD34 + cells, which are enriched for stem cells and immature progenitor cells.
18 CD34 3+ cells were directly sorted as one cell/well into wells containing 0.1 ml semisolid culture medium. ase (neo) gene, pLhEpoRSN, was constructed from a pLXSN vector digested with EcoRI/XhoI and the EpoR coding sequences were inserted into the coding site of pLXSN vector. 13 The retroviral vector encoding H-ras with the neo gene, pMV7-H-ras, was constructed from a pMV7 vector digested with EcoRI/HindIII and the H-ras coding sequences were inserted at the coding site of pMV-7 vector. 16 The pLXSN and pMV7 vectors were used as controls. The retroviral packaging cell line, PA317, was maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% FCS to produce high-titer helper-free viruses. Viral supernant was harvested and filtered through 0.45 m and 0.22 m filters and stored at −80°C until use. The titer for pLEpoRSN and pMV7-H-ras viruses was 1-2 × 10 6 particles/ml as assessed on NIH3T3 cells.
Retroviral vectors and packaging cells
Retroviral gene transduction and colony assay
CD34 3+ cells were sorted as one cell/well in the semisolid medium containing Iscove's modified Dulbecco's medium (IMDM; Gibco BRL, Gaithersberg, MD, USA), 1% methylcellulose, 30% fetal calf serum (FCS; Hyclone, Logan, UT, USA), 0.1 mmol/l hemin (Eastman Kodak, Rochester, NY, USA), 2 mmol/l l-glutamine, 0.1 mmol/l ␤-mercaptoethanol, and in the presence of recombinant human (rhu) steel factor (SLF) (R&D Systems, Minneapolis, MN, USA), Epo (Amgen, Thousand Oaks, CA, USA), granulocyte-macrophage colony-stimulating factor (GM-CSF), and IL-3 (kind gifts from Immunex, Seattle, WA, USA) and used at 50 ng, 1 U, 200 U and 200 U per ml, respectively. The cells were cultured for 2 days, then transduced by adding viral supernatant at 20 l/well with 8 g/ml polybrene (Aldrich Chemical Company, Milwaukee, WI, USA) as described previously. [13] [14] [15] [16] [17] 19 The cells remained in the same cultures for another 14 days for colony formation. It was noticed that 2 days after prestimulation, before addition of viral supernatant, fewer than 5% of the cells formed doublets and the predicted short halflife of the virus preparation suggests that Ͼ95% of wells have been exposed to gene transduction at single cell level. Colony-forming unit (CFU)-GM, burst-forming unit (BFU)-erythroid (E), and CFU-granulocyte, erythrocyte, macrophage, megakaryocyte (GEMM)-derived colonies were scored under an inverted microscopy.
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Statistics
The probability of significant differences between groups was determined by 2 test.
Polymerase chain reaction (PCR) and reverse transcriptase polymerase chain reaction (RT-PCR) analysis
Genomic DNA and RNA were isolated from individual colonies and used for PCR and RT-PCR analysis as described previously. [13] [14] [15] [16] [17] 19 Two pairs of primers were used at 1 m in the PCR reaction. The primers and the PCR conditions for amplifying the transduced EpoR and H-Ras were used as described previously. 13, 16 The primers for pLhEpoRSN were used as described. [13] [14] [15] The primers of pMV7-H-ras were 5′-TCT CGC TGT TCC TTG GGA GGG T-3′ (sense, located in the LTR of MV7 vector) and 5′-ACT ACC TGT TTC CGG TAG GAG T-3′ (anti-sense, located at the Hras cDNA sequences). 16 Thirty-five thermal cycles (94°C for 1 min to denature the DNA, 65°C for 1 min for primer annealing, and 72°C for 2 min for primer extension) were used. 13, 16 Ten l of reaction mixture were electrophoresed, transferred to a membrane, and hybridized with 32 P dCTPlabeled hEpoR or H-ras fragment used as a probe as previously described, 13, 16 and hybridization was performed overnight at 42°C, filters were washed, dried and exposed to X-ray at −70°C.
Results
Effects of co-transduction of EpoR and H-Ras cDNAs on colony formation by single CD34 3+ cells
Single CD34 3+ CB cells were sorted as one cell/well and transduced with EpoR and/or H-ras cDNAs to determine if an enhanced biological effect could be observed. Results are expressed as percent wells with growth from a total of 384 to 1232 wells per each group from a total of five separate experiments and are shown in Figure 2 . In the presence of SLF (50 ng/ml), IL-3 (200 U/ml), GM-CSF (200 U/ml) and Epo (1 U/ml), colony formation by BFU-E was significantly increased by cells transduced with either hEpoR (10.2%) or H-ras (5.3%) cDNA compared to pLXSN as mock (2.6%) virus-transduced cells (Figure 2 ). Since the results from transduction of pLXSN or pMV7 were similar, pLxSN was used as a mock control for all the experiments (data not shown). This number of BFU-E colonies was further enhanced when both genes (14.5%) were introduced simultaneously into CD34
3+ cells compared to the single gene transduction. Colony formation by CFU-GEMM was slightly increased in cells transduced with hEpoR (11%) or H-ras (9.9%) cDNA compared to mock (8.7%) virustransduced cells. No further enhancement was noticed in cells co-transduced with both genes compared to the single gene-transduced cells. Colony size was determined by cell counts per colony in 60 colonies each for cell populations from a total of three separate experiments (Figure 3 ). The number of cells per colony derived from EpoR or H-rastransduced cells was 52-99% and 101-252% greater than Bone Marrow Transplantation that in colonies from mock-transduced cells for all types of colonies. The greatest number of cells per colony was observed in colonies derived from cells transduced with both genes (358-389%), which was significantly greater than cells transduced with single gene alone. Little or no growth was seen in cells transduced with EpoR and/or Hras without the addition of exogenously added cytokines. These results indicate that the enhancing effects of co-transduction with both EpoR and H-ras are acting directly on the progenitors. In order to rule out the possibility that the enhancing effects noticed in co-transduced cells were due to the co-transduction of two different viruses, cells were co-transduced with hEpoR and MV7 viruses, and no enhancing effects beyond that of the hEpoR-gene transduced cells were noticed (data not shown).
Proviral integration and expression of pLhEpoRSN and/or pMV7-H-ras by PCR and RT-PCR analysis
Individual colonies derived from single CD34 3+ cells cotransduced with hEpoR and H-ras cDNAs were removed from wells, and DNA and RNA were extracted for PCR and RT-PCR analysis. Results are from a total of 55 colonies for each type of progenitor cell from two separate experiments (Figure 4) . The 625 bp (transduced pLhEpoRSN gene) or 510 bp (transduced pMV7-H-ras gene) fragment was detected, respectively, by PCR ( Figure 4a ) and RT-PCR (Figure 4b ) analysis at 45-62% and 48-58% detection efficiencies, while 31% transduction efficiency was noted for two genes in the same cell. More than 30 colonies derived from single mock-transduced cells were negative for the hEpoR and/or H-ras cDNAs.
Discussion
We have previously reported that transduction of a human EpoR 13 or a H-ras 16 cDNA into single CD34 3+ CB cells increased Epo-dependent colony formation by BFU-E and CFU-GEMM. Based on these studies, we felt that it would be interesting to determine if the increased number and size of erythroid containing colonies could be further increased by co-transduction of both EpoR and H-ras simultaneously into single CD34 3+ CB cells, a population of cells highly enriched for hematopoietic stem/progenitor cells. Consistent with our previous results, colony formation by BFU-E was significantly increased in cells transduced with either EpoR or H-ras cDNA. More interestingly, the increased numbers and size of BFU-E colonies were further enhanced in the present studies, when both cDNAs were introduced simultaneously into single CD34 3+ cells, suggesting an interacting role or a correlation of H-ras and EpoR genes in erythroid proliferation/differentiation of these primary hematopoietic stem/progenitor cells. The mechanisms of this interaction are not clear. Currently, it is difficult to study this at the molecular level in primary cells because of the small number of cells available in this population. It is of some interest that while transduction of EpoR and Hras cDNAs did not significantly influence numbers of CFU-GM colonies formed (Figure 2 Figure 3 Influence of co-transduction of EpoR and H-ras cDNAs on the size of colonies derived from single CD34 3+ cells transduced with EpoR, or H-ras or co-transduced with both genes or mock-transduced, and grown in the presence of SLF, IL-3, GM-CSF and Epo. The 60 largest CFU-GM, BFU-E and CFU-GEMM colonies per group were removed from a total of two separate experiments, and cell numbers per colony were counted. a Significant differences compared with mock virus control; P Ͻ 0.05. b Significant differences of single gene transduction with cotransduction of both genes; P Ͻ 0.05. colonies ( Figure 3) . It is possible that the EpoR may be involved in signaling of cells that are missing key components or stimuli necessary for erythroid differentiation.
The most likely interpretation of these results is that transduction of H-ras influences enhanced proliferative signals in cells in which the EpoR gene has been inserted, and both genes might be involved in activation of the serine/threonine kinase Raf. The serine/threonine kinase Raf-1 is believed to play a regulatory role in the transmission of a variety of mitogenic stimuli and to induce cell growth and differentiation. 20, 21 It is well documented that signaling pathways transmitted through Ras activate Ras effector molecules, the best characterized of which is the serine/threonine kinase Raf. Through interaction with Raf-1, Ras activates and phosphorylates MEK-1, leading to activation of the mitogen-activated protein (MAP) kinase cascade, and then in turn initiates the transcription factors, which can bind to nuclear c-fos and c-jun to induce proliferation. 10, 22 This Raf-1/MEK/MAP kinase pathway is a requirement for DNA synthesis in certain types of cells. However, these signal transduction pathways are not unique to the EpoR, and they are also activated by many growth factor receptors. 23 Although signals induced by Epo have been studied extensively by using cell lines, controversial results have been reported as to the role of signaling molecules in erythroid differentiation. Binding of a growth factor to its tyrosine kinase receptor at the cell surface leads to p21 ras activation that in turn recruits Raf-1 to the plasma membrane 24 through a direct interaction with Raf-1. Unlike members of the tyrosine kinase receptor superfamily, the cytokine receptors do not have intrinsic tyrosine kinase activity, but are dependent mainly upon the Janus kinase (JAK) family of tyrosine kinases with which they form a stable complex. 25, 26 EpoR belongs to the cytokine receptor family that comprises receptors for various interleukins, GM-CSF, G-CSF and growth hormones. The special characteristic of this family of receptors is that they are switched on (ie the receptor is activated) and transduce signals to the interior of the cell by the formation of homoor hetero-oligomers (dimers or trimers). EpoR is activated by the formation of homodimers. 25 Physiologic concentrations of Epo mediate rapid phosphorylation and activation of Raf-1 in the murine cell lines, which proliferate in response to Epo, suggesting that Raf-1 is a necessary component in Epo-induced proliferation. 23, 27 The growth factor-mediated phosphorylation and auto-phosphorylation of Raf-1 forms the basis for a plausible erythroid growth programme featuring Raf-1 as a crucial component.
It is known that the JAK2/STAT5 pathway is involved in Epo-dependent erythroid proliferation and differentiation. [28] [29] [30] [31] Our previous study demonstrated that transduction of wild-type H-ras, but not dominant-negative RAS1, cDNA into TF1 and CB CD34 3+ cells induced erythroid differentiation in these cells. 16 It was also demonstrated that the increases in erythroid-specific gene expression were associated with expression of pre-mRNA of the EpoR gene in the TF1 cells transduced with H-ras. 16 Those results also suggest a link between EpoR and H-ras genes. Our present data support a possible interaction between EpoR and Hras signaling pathways in primary hematopoietic progenitor cells.
Another possible explanation is that the increased erythropoiesis might be due to the interactive effect of the EpoR and H-ras signaling pathways. It is well known that the erythroid transcription factor NF-E2 plays a critical role in erythroid differentiation as an enhancer-binding protein for expression of the ␤-globin gene. NF-E2 activity can be activated significantly by the Ras-Raf-MAP kinase signaling cascade. 32 Our previous studies have demonstrated an increased expression of ␤-globin gene in H-ras-transduced TF1 cells in the absence and presence of Epo. Hence, transduced H-ras might be able to facilitate erythroid differentiation by increasing expression of some erythroid-specific genes, such as the ␤-globin gene, at the late stage of erythroid differentiation. It is clear that EpoR plays a major role in the later stages of terminal differentiation. In our case, simultaneous co-transduction of both EpoR and Ras genes into CD34 3+ cells could activate and strengthen erythroid differentiation pathways of both EpoR and Ras independently and therefore increase the numbers and size of erythroid containing colonies. The results described in this paper could be potentially relevant for gene therapy of hematological disorders or hemoglobinopathies. The mechanism involved between the EpoR and H-ras signaling pathways and their role in erythroid differentiation will need to be addressed in the future.
